Restricted accessResearch articleFirst published online 1991-1
T4+ Cell Depletion as a Major Risk Factor for AIDS-Related Complex and AIDS. Longitudinal Study of 253 HIV-Antibody Positive Heroin Addicts from Northern Italy
We enrolled 253 HIV-antibody positive heroin addicts without HIV-related disease (n = 81) or with persistent generalized lymphadenopathy (n = 172) in a prospective study to evaluate clinical progression to AIDS related complex (ARC) or AIDS and to identify factors of possible prognostic relevance. Follow-up lasted between 6 and 40 months (median 12 months). According to the non-parametric Cox's model the only significant (P<0.001) prognostic variable was T4+ cell count considered in three classes: >800/μl (no depletion), 400–800/μl (moderate depletion) and <400/μl (absolute depletion). Subjects with T4+ cell count of <400/μl had a risk of developing ARC or AIDS that was 6.46 and 1.98 higher than those with values of >800/μl or between 400 and 800/μl respectively. The estimated probability of progression to ARC or AIDS was 0.029, 0.056 and 0.172 at one year in subjects with T4+ cell count of >800/μl, 400–800/μl and <400/μl, respectively, and 0.2%, 0.501, and 0.896 at two years.
TaylorJMGSchwartzKDetelsR.The time from infection with human immunodeficiency virus (HIV) to the onset of AIDS. J Infect Dis1986; 154: 694–7
2.
GoedertJJBiggarRJWeissSH. Three-year incidence of AIDS in five cohorts of HTLV-III-infected risk group members. Science1986; 231: 992–5
3.
KaplanJESpiraTJFishbeinDBBozemanLHPinskyPFSchonbergerLB. A six-year follow-up of HIV-infected homosexual men with lymphadenopathy. Evidence for an increased risk for developing AIDS after the third year of lymphadenopathy. JAMA1988; 260: 2694–7
4.
MossARBacchettiPOsmondD. Seropositivity for HIV and the development of AIDS or AIDS related condition: Three year follow up of the San Francisco General Hospital cohort. BMJ1988; 296: 745–50
5.
GoedertJJKesslerCMAledortLM. A prospective study of human immunodeficiency virus type 1 infection and the development of AIDS in subjects with hemophilia. N Engl J Med1989; 321: 1141–7
6.
PolkBFFoxRBrookmeyerR. Predictors of the acquired immunodeficiency syndrome developing in a cohort of seropositive homosexual men. N Engl J Med1987; 316: 61–6
7.
MossAR. Predicting who will progress to AIDS. BMJ1989; 297: 1067–8
8.
PedersenCLindhardtBOJensenBL. Clinical course of primary HIV infection: consequences for subsequent course of infection. BMJ1989; 299: 154–7
9.
CurranJWJaffeHWHardyAMMorganWMSelikRMDonderoTJ. Epidemiology of HIV infection and AIDS in the United States. Science1988; 239: 610–16
10.
World Health Organisation Collaborating Center on AIDS. AIDS surveillance in Europe, situation by October 31, 1986. Geneva: WHO 1986
11.
Centers for Disease Control. Classification system for human T-lymphotropic virus type III/lymphadenopathy-associated virus infections. Ann Intern Med1986; 105: 234–7
12.
Centers for Disease Control. Revision of the case definition of acquired immunodeficiency syndrome for national reporting. MMWR1985; 34: 374–5
13.
BerksonJGageRP. Calculation of survival rates for cancer. Proc Staff Meet Mayo Clin1950; 25: 270–86
14.
MantelN.Evaluation of survival data and two new rank order statistics arising in its considerations. Cancer Chemother Rep1966; 50: 163–70
15.
CoxDR. Regression models and life tables (with discussion). J R Stat Soc1972; 34: 187–220
16.
KalbfleischJDPrenticeRL. The statistical analysis of failure time data. New York: John Wiley1980
17.
HopkingsA.Survival analysis with covariate—Cox model. In: DixonWJ, eds. BMDP statistical software. Berkeley: University of California Press, 1981
18.
EspinozaPBouchardIBuffetC. High prevalence of infection by hepatitis B virus and HIV in incarcerated French drug addicts. Gastroenterology1987; 11: 288–92
19.
FauciAS. NIH conference. The acquired immunodeficiency syndrome: An update. Ann Intern Med1985; 102: 800–13
20.
ConteDFerroniPLoriniGP. HIV and HBV infection in intravenous drug addicts from Northeastern Italy. J Med Virol1987; 22: 299–306
21.
NicolosiALazzarinA.HIV seroconversion rates in intravenous drug abusers from Northern Italy. Lancet1989; ii: 269
22.
WardJWBushTJPerkinsHA. The natural history of transfusion-associated infection with human immunodeficiency virus. N Engl J Med1989; 321: 947–52
23.
AngaranoGPastoreGMonnoLSantantonioTLuchenaNSchiraldiO.Rapid spread of HTLV-III infection among drug addicts in Italy. Lancet1985; ii: 1302
24.
LaceyCJNForbesMAWaughMA. Serum β2-microglobulin and human immunodeficiency virus infection. AIDS1987; 1: 123–7
25.
WeberJNRogersLAScottK. Three-year prospective study of HTLV-III/LAV infection in homosexual men. Lancet1986; i: 1179–82
26.
MelbyeMBiggarRJEbbesenP. Long-term seropositivity for T-lymphotropic virus type III in homosexual men without the acquired immunodeficiency syndrome: Development of immunologic and clinical abnormalities. A longitudinal study. Ann Intern Med1986; 104: 496–500
27.
FrancisDPJaffeHWFultzPNGetchellJPMcDougalJSFeorinoPM. The natural history of infection with the lymphadenopathy-associated virus human T-lymphotropic virus type III. Ann Intern Med1985; 103: 719–22
